Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2005
09/27/2005CA2173876C Alkoxy alkyl carbamates from imidazo(1,2-a)pyridines
09/22/2005WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient
09/22/2005WO2005087749A1 2-aminoquinazoline derivative
09/22/2005WO2005087257A1 Remedy for repairing cartilage tissue having crosslinked gelatin gel as support
09/22/2005WO2005087252A1 Use of dm43 and its fragments as matrix metalloproteinases inhibitor
09/22/2005WO2005087248A1 Drug having inhibitory effect on the differentiation and/or proliferation of osteoclasts
09/22/2005WO2005000327A3 Use of bacilli bacteria in order to produce a composition for the prevention of vertebral compression syndrome in salmonids
09/22/2005WO2000075279A3 Nucleotide sequences for gene regulation and methods of use thereof
09/22/2005US20050209459 Processes for the preparation of 1,5-diryl-3-substituted-pyrazoles
09/22/2005US20050209329 Potentiation of therapeutic effects of fatty acids
09/22/2005US20050209286 RXR activating molecules
09/22/2005US20050209261 Rho-kinase inhibitors
09/22/2005US20050209252 Using an indazole compound
09/22/2005US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors
09/22/2005US20050209225 Substituted indoles and their use as integrin antagonists
09/22/2005US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline
09/22/2005US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209198 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
09/22/2005US20050209192 Autoimmune disorders; modulating protein kinase C activity
09/22/2005US20050209191 1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209159 Effectors of dipeptidyl peptidase IV for topical use
09/22/2005US20050209144 Protein formulations
09/22/2005US20050208580 Novel protein and method for producing the protein
09/22/2005US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
09/22/2005US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin
09/22/2005US20050208035 Nutritional composition for treating an immune condition
09/22/2005DE10152351B4 Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat Solid pharmaceutical formulation for a Piperazinharnstoffderivat
09/22/2005CA2560098A1 2-aminoquinazoline derivative
09/21/2005EP1577317A1 Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
09/21/2005EP1577299A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient
09/21/2005EP1577288A1 Selective estrogen receptor modulators
09/21/2005EP1576964A1 Protease inhibitor
09/21/2005EP1576954A1 Preferential inhibition of release of pro-inflammatory cytokines
09/21/2005EP1576893A1 Composition containing isoflavone of high purity at high concentration and process for producing the same
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576160A2 Borrelidin-producing polyketide synthase and its use
09/21/2005EP1576090A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/21/2005EP1576088A2 Dominant negative proteins and methods thereof
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
09/21/2005EP1575982A1 Promoter for the production of hyaluronic acid containing ginsenoside compound k
09/21/2005EP1575606A1 Treatment of osteoarthritis
09/21/2005EP1575591A1 Heterocycles and uses thereof
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575521A2 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575481A2 Methods to increase or decrease bone density
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1542728A4 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
09/21/2005EP1406694A4 Electro-medical device for use with biologics
09/21/2005EP1377560B1 Piperazine derivatives as tachykinin antagonists
09/21/2005EP1303501B1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
09/21/2005EP1296689B1 Method of administering bisphosphonates
09/21/2005EP1294679B1 Beta-amino acid nitrile derivatives
09/21/2005EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005EP1129188B1 Pge synthase and methods and means for modulating its activity
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP0712303B1 Skin patches comprising testosterone and optionally estrogen
09/21/2005CN1671866A PTHrP-based prediction and diagnosis of bone disease
09/21/2005CN1671856A Novel physiologically active substances
09/21/2005CN1671744A Low molecular weight oversulfated polysaccharide
09/21/2005CN1671730A Oligonucleotide-containing pharmacological compositions and their use
09/21/2005CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
09/21/2005CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/21/2005CN1671695A Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors
09/21/2005CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors
09/21/2005CN1671671A 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
09/21/2005CN1671668A 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
09/21/2005CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671424A Decoy composition for treating and preventing inflammatory disease
09/21/2005CN1671396A Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
09/21/2005CN1671391A Novel methods and compositions for alleviating pain
09/21/2005CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1671371A Combination of an aromatase inhibitor with a bisphosphonate
09/21/2005CN1669577A Chinese medicine preparation for treating osteoporosis and fracture and preparation process thereof
09/21/2005CN1669562A Muscles and bones rehabilitation plaster and preparation method thereof
09/21/2005CN1669555A Ointment with inflammation diminishing and pain reducing function for treating arthrophlogosis using copper complex compound and preparation method thereof
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
09/21/2005CN1219535C Swelling eliminating and pain relieving plaster
09/21/2005CN1219526C Chinese medicine for bone-setting and method for preparing same
09/21/2005CN1219524C Medicine for treating femoral head necrosis and its preparation method
09/20/2005US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
09/20/2005US6946478 Compounds
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance
09/20/2005US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005US6946121 Composition in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085294A1 Hyaluronic acid/methotrexate compound
09/15/2005WO2005085267A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
09/15/2005WO2005085265A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
09/15/2005WO2005085237A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
09/15/2005WO2005085223A1 Composition for prevention and/or treatment of bone disease, functional food or health food containing the composition, and medicinal preparation containing the composition as active ingredient
09/15/2005WO2005085212A1 Substituted pyrimidine derivative
1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 820